Breastmilk, SARS-CoV2
Conditions
Brief summary
The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection. Human milk is the best form of infant nutrition providing significant protection against many illnesses for term and preterm infants. The impact of a pandemic on breastfeeding is unknown. This study seeks to address this public health issue. Breastmilk will be collected from mothers positive for COVID-19. Samples will be analyzed for the COVID-19 virus specific nucleic acid and antibody in real-time and results will be immediately disseminated to relevant organizations to inform local, national and international guidelines surrounding breastfeeding to protect the health of infants.
Interventions
OTHERCOVID-19
Exposure of interest for this observational study is current COVID-19 positive status or COVID-19 positive status during pregnancy
Sponsors
University of Toronto
Sinai Health System
Deborah O'Connor
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Current COVID-19 positive status or COVID-19 positive status during pregnancy * Intent to breastfeed or currently breastfeeding
Exclusion criteria
\- None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of SARS-CoV-2 in breastmilk | 2-6 months | To describe the presence of SARS-CoV-2 nucleic acid in human milk samples collected from mothers positive for COVID-19 |
| SARS-CoV-2 antibody in breastmilk | 2-6 months | To describe the presence of SARS-CoV-2 antibody in human milk samples collected from mothers positive for COVID-19 |
Countries
Canada
Outcome results
None listed